Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
Phenobarbitone
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 




 

 
HOME >> PRODUCTS >> Taj Products >> MSDS Download
Taj  ALL Products View Products According to Category

Phenobarbitone
 

Read the MSDS information for this product.



 
Read the MSDS ( Material Safety Data Sheet ) for this medication. (PDF)
      For more information, please see Full Prescribing Information.
 


WARNINGS
1. Habit forming: Phenobarbital may be habit forming. Tolerance, psychological and physical dependence may occur with continued use. (See ADVERSE REACTIONS: Drug Abuse and Dependence). To minimize the possibility of overdosage or the development of dependence, the prescribing and dispensing of sedative-hypnotic barbiturates should be limited to the amount required for the interval until the next appointment. Abrupt cessation after prolonged use in the dependent person may result in withdrawal symptoms, including delirium, convulsions, and possibly death. Phenobarbital should be withdrawn gradually. (See ADVERSE REACTIONS: Drug Abuse and Dependence.)

2. Acute or chronic pain: Caution should be exercised when Phenobarbital is administered to patients with acute or chronic pain, because paradoxical excitement could be induced or important symptoms could be masked. However, the use of phenobarbital as a sedative in the postoperative surgical period and as an adjunct to cancer chemotherapy is well established.

3. Use in pregnancy: Phenobarbital can cause fetal damage when administered to a pregnant woman. Retrospective case-controlled studies have suggested a connection between the maternal consumption of phenobarbital and higher than expected incidence of fetal abnormalities. Following oral administration, Phenobarbital readily crosses the placental barrier and is distributed throughout fetal tissues with highest concentrations found in the placenta, fetal liver, and brain.

Withdrawal symptoms occur in infants born to mothers who receive phenobarbital throughout the last trimester of pregnancy. (See ADVERSE REACTIONS: Drug Abuse and Dependence.) If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.

4. Synergistic effects: The concomitant use of alcohol or other CNS depressants may produce additive CNS depressant effects.

 

 

If you do not have the Acrobat Reader installed on your computer, download the plug-in and simply follow the instructions for installation. It is available without charge from Adobe®.com.

This link is provided as a convenience. Taj Pharma is not responsible for the content of this linked page.


 


Note :
This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).
 

 

 

   CROPRAM ® Taj Products
Product Gallery
PDF Download
Doc Download
MSDS Download
COA Download
 Prescription Products (Rx)
 

 

 

 

 


 

 

 

              
 Print page   Send by mail

 


 

 

 

 

 

 

 

 

 

 

 

 

 


 

  Cropram™ Phenobarbital Tablets 15mg 30mg 60mg 100 mg manufacturers (PHENOBARBITAL) manufacturers Phenobarbital Manufacturer Patient Information Leaflet Phenobarbital Tablets 30mg 60mg Phenobarbital Tablets 30mg 60mg phenobarbital (phenobarbitone)  Phenobarbital Tablets 30mg 60mg History - Indications - Other uses - Side effects epilepsy phenobarbitone Phenobarbital tables phenobarbital sodium tablets of 15 30 60 and 100 mg phenobarbitone Importer Exporter Manufacturers Buyers Suppliers Importers and Exporters Phenobarbital CAS 50-06-6 phenobarbital wholesalers & distributorsPhenobarbital Sellers Phenobarbital Manufacturers Phenobarbital Exporters Phenobarbital WholesalersTreating and preventing seizures and treating sleep disorders – Taj Pharma India Cropram (PHENOBARBITAL) manufacturers Phenobarbital tables phenobarbital sodium tablets of 15 30 60 and 100 mg and suppliers Exporterphenobarbital phenobarbital products phenobarbital services phenobarbital information phenobarbital supplier Cropram™ (PHENOBARBITAL) Phenobarbital Tablets 15mg 30mg 60mg 100 mg manufacturers and suppliers Exporterphenobarbital phenobarbital products phenobarbital services phenobarbital information phenobarbital suppliers – Taj Pharma India phenobarbital sodium tablets of 15 30 60 and 100 mg PHENOBARBITAL phenobarbital phenobarbital products phenobarbitone phenobarbital services phenobarbital information phenobarbital suppliers phenobarbital manufacturers phenobarbital factory phenobarbital exporters phenobarbital importers phenobarbital buyers phenobarbital companiesPhenobarbital CAS 50-06  product supplier suppleir suppliers vendor vendors price prices phenobarbital manufacturers phenobarbital suppliersphenobarbital exporters wholesalers phenobarbital Distributors traders sellers import export trade leads sell offers selling leads  
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

`

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 www.tajpharma.com

   


 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement